Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
P5 PREMATURE in utero CLOSURE OF THE DUCTUS ARTERIOSUS DUE TO INGESTION OF VOLTAREN DURING PREGNANCY Mas C, Menahem S Paediatric Cardiology Unit, Monash Medical Centre, Clayton, Victoria 3168 Premature closure of the ductus arteriosus can lead to foetal hydrops and death if not recognised promptly. A case of probable antenatal closure of the duct is presented. The reason for early closure was the maternal ingestion of an non-steroidal anti-inflammatory drug (sodium diclofenac) during weeks 34 and 35 of gestation for severe pain. A sinusoid CTG lead to antenatal ultrasonography which revealed cardiomegaly with marked right atrial dilatation and right ventricular enlargement and hypertrophy. An emergency caesarian section was practiced at 41 weeks of pregnancy following failed induction. It was a stillbirth. The patient required cardiac massage and endotracheal adrenaline and ventilation. Hepatomegaly and gallop rhythm suggested right heart failure. An echocardiogram performed 30 minutes after birth showed a closed ductus arteriosus with a hyperdynamic well contracting left ventricle compressed by a right ventricle which was dilated and hypocontractile. The right atrium was dilated with the atrial septum bulging to the left. There was a patent foramen ovale with right to left shunting. Moderate tricuspid regurgitation was identified. The findings suggested persistent pulmonary hypertension, the calculated doppler systolic pulmonary artery pressure being 64 mmHg (systemic blood pressure 75/50). The infant was ventilated for 24 hours and treated with diuretics for four weeks. At one year follow up, the patient remains asymptomatic and the cardiac size returned to normal. Premature closure of the ductus arteriosus should be considered in any pregancy following ingestion of non-steroidal anti-inflammatory drugs during the third trimester. Doppler monitoring of the foetal duct should be carried out to determine if premature closure is occurring and if this is the case, the clinician should decide whether to stop the drug or deliver the baby.